A RAMAN-SPECTROSCOPIC STUDY OF ACETYLCHOLINE RECEPTOR-RICH MEMBRANES FROM TORPEDO-MARMORATA - INTERACTION OF THE RECEPTOR WITH CARBAMYLCHOLINE AND (-TUBOCURARINE())
D. Aslanian et al., A RAMAN-SPECTROSCOPIC STUDY OF ACETYLCHOLINE RECEPTOR-RICH MEMBRANES FROM TORPEDO-MARMORATA - INTERACTION OF THE RECEPTOR WITH CARBAMYLCHOLINE AND (-TUBOCURARINE()), Biochimica et biophysica acta, 1148(2), 1993, pp. 291-302
Raman spectroscopy is used to determine structural features of alkali-
treated subsynaptic membrane fragments from Torpedo marmorata electric
organ, rich in native functional AcChR. Distinct vibrations attributa
ble to the membrane proteins and lipids were identified and studied be
fore and after addition of the agonist carbamylcholine and the competi
tive antagonist (+)-tubocurarine. The protein secondary structure dete
rmined by using amide-I polypeptide vibrational analysis, indicates 47
% alpha-helices, 25% beta-sheets, 18% turns and 11% undefined structur
e. The secondary structure of the AcChR molecule was not subject to la
rge modifications upon addition of carbamylcholine. But, the presence
of the (+)-tubocurarine leads to detectable changes in the amide-I reg
ion which might be interpreted as reflecting different contributions o
f alpha-helices and turns in the secondary structure. In addition, Ram
an spectra provide information about the environment of aromatic amino
acids (tyrosine and tryptophan), the (C-C) bonds, the CH2 and CH3 gro
ups of aliphatic side chains, as well as the disulfide (S-S) and cyste
in (C-S) bonds. The tyrosines seem 'exposed' to the aqueous medium. Th
e Raman spectra of the AcChR-carbamylcholine complex suggest 'exposed'
tryptophans, while those of the unliganded membrane-bound AcChR or of
the receptor with (+)-tubocurarine are shown 'buried'. The disulfide
bridges in the AcChR subunits show identical conformation in the absen
ce and presence of carbamylcholine. On the contrary, considerable chan
ges are found in the AcChR-(+)-tubocurarine complex. Carbamylcholine a
nd especially (+)-tubocurarine decrease lipid fluidity.